Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

Human evolution’s biggest mystery, which emerged 15 years ago from a 60,000-year-old pinkie finger bone, finally started to ...

Before you stock up on cheap cleaning supplies, learn which Dollar Tree products actually work. Trump erupts over Mar-a-Lago search after new email report The US may have a secret weapon against ...

As of Wednesday, December 24, Inovio Pharmaceuticals, Inc.’s INO share price has surged by 5.13%, which has investors questioning if this is right time to sell.

CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...

As of Wednesday, December 24, Repare Therapeutics Inc.’s RPTX share price has surged by 19.82%, which has investors questioning if this is right time to sell.

TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight ...

Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership ...

CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Despite coming back in style, the dangers of tanning beds never went away, particularly one side effect that’s more than skin deep and literally changing DNA.